Recent News

• 03.11.2025 - PureTech to Present at the Leerink Partners Global Healthcare Conference
• 03.11.2025 - PureTech to Present at the Leerink Partners Global Healthcare Conference
• 03.11.2025 - PureTech Founded Entity Seaport Therapeutics Appoints Robert J. Hombach to its Board of Directors as Audit Committee Chair
• 03.11.2025 - PureTech Founded Entity Seaport Therapeutics Appoints Robert J. Hombach to its Board of Directors as Audit Committee Chair
• 02.25.2025 - PureTech to Present at the Leerink Partners Global Healthcare Conference
• 02.25.2025 - PureTech to Present at the Leerink Partners Global Healthcare Conference
• 02.12.2025 - Molecular Pharmaceutics: Optimizing Triglyceride Prodrugs of a Model Immunomodulator: Conjugation through the Phenol of Mycophenolic Acid (MPA) Markedly Promotes Lymphatic Drug Transport
• 02.12.2025 - Molecular Pharmaceutics: Optimizing Triglyceride Prodrugs of a Model Immunomodulator: Conjugation through the Phenol of Mycophenolic Acid (MPA) Markedly Promotes Lymphatic Drug Transport
• 02.12.2025 - PureTech Founded Entity Seaport Therapeutics Announces the Publication of New Research Demonstrating Increased Lymphatic Transport with up to 55 Percent Drug Absorption via Lymphatics with Glyph™ Platform
• 02.12.2025 - PureTech Founded Entity Seaport Therapeutics Announces the Publication of New Research Demonstrating Increased Lymphatic Transport with up to 55 Percent Drug Absorption via Lymphatics with Glyph™ Platform

Recent Filings

• 02.12.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors